"One and a half x is the new 10x."
– Kurt von Emster, partner with VenBio, during a panel at the 2011 BIO Investor Forum
"Instead of asking the FDA to lower the bar, just get drug developers that can jump higher."
– Sanjay Shukla, CEO of RxMD, of the current regulatory environment
"You almost have to negotiate the divorce before you negotiate the marriage."
– Michael Margolis, managing director with Roth Capital Partners, talking about ironing out all the details of a multiple-asset partnership
"I think if we're sitting here three or four years from now, we're not even using the terminology 'corporate venture' and 'traditional venture.'"
– Brian McVeigh, vice president of worldwide business transactions and investment management at GlaxoSmithKline plc